{"@id":"https://bioecon.ru/technology/rare-ginsenosides-biocatalytic-synthesis/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/rare-ginsenosides-biocatalytic-synthesis/","json":"https://cn.bioecon.ru/api/v1/technology/rare-ginsenosides-biocatalytic-synthesis/index.json"},"id":"rare-ginsenosides-biocatalytic-synthesis","industries":["pharma","wellness-prevention"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/wellness-prevention/"],"suppliers":["https://bioecon.ru/companies/biophelion-gmbh/","https://bioecon.ru/companies/vtr-biotech/","https://bioecon.ru/companies/aminoverse-bv/","https://bioecon.ru/companies/suterra/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/enzymaster/","https://bioecon.ru/companies/eversyn-gmbh/","https://bioecon.ru/companies/isomerase/","https://bioecon.ru/companies/pi-industries-ltd/","https://bioecon.ru/companies/digzyme/","https://bioecon.ru/companies/global-bioenergies/"]},"maturity":8,"name":"酶法与工程酵母合成稀有人参皂苷（Rg3/Rh2/Compound K）技术","regions":["us","cn","eu","ru"],"risk":"low","section":"technology","sector":"pharma-health","sources":[{"date":"2026-11-15","entity":"ncbi.nlm.nih.gov","kind":"research","urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905321/"]},{"date":"2026-11-15","entity":"sciencedirect.com","kind":"research","urls":["https://doi.org/10.1016/j.biortech.2023.129400"]}],"stages":[{"n":1,"title":"天然主参皂苷提取或工程酵母从头合成PPD"},{"n":2,"title":"专一性重组糖苷酶多位点精准分子剪切"},{"n":3,"title":"反相高压聚合物树脂连续梯度色谱分离"},{"n":4,"title":"药用乙醇真空重结晶与无菌冻干精制"}],"summary":"采用现代生物制造、绿色催化与精细分离工程的酶法与工程酵母合成稀有人参皂苷（Rg3/Rh2/Compound K）技术产业化制造与应用技术。以种植人参/西洋参茎叶粗提物（富含Rb1、Rc、Rd）为原料，或利用重组酿酒酵母工程菌从头高密度发酵合成原人参二醇（PPD）前体。。","url":"/technology/rare-ginsenosides-biocatalytic-synthesis/","verified":null}